Importantly, CGS1 is significantly associated with CD8 T cell–-mediated eradication of cancer cells and potential response to anti-PD-L1 or anti-PD-1 treatment, although this finding needs further validation in preclinical and clinical studies. The gene discussed is CD8A; the disease is cancer.